{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T17:16:59Z","timestamp":1726507019827},"reference-count":40,"publisher":"Consortium Erudit","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["smq"],"abstract":"<jats:p>L\u2019article examine les associations entre l\u2019exposition \u00e9lev\u00e9e aux m\u00e9dicaments psychotropes, la pr\u00e9sence d\u2019un diagnostic de trouble mental et les caract\u00e9ristiques sociod\u00e9mographiques chez la population adulte. Un questionnaire a \u00e9t\u00e9 pass\u00e9 par entrevue aupr\u00e8s de 2433 personnes de 15 ans et plus dans le cadre de l\u2019enqu\u00eate ZEPSOM (zone \u00e9pid\u00e9miologique du sud-ouest de Montr\u00e9al). Les d\u00e9terminants de leur consommation de psychotropes ont fait l\u2019objet d\u2019analyses bivari\u00e9es et de r\u00e9gression logistique multivari\u00e9e. Une association bivari\u00e9e significative a \u00e9t\u00e9 observ\u00e9e entre la consommation de somnif\u00e8res, d\u2019anxiolytiques et d\u2019antid\u00e9presseurs et \u00eatre plus \u00e2g\u00e9, \u00eatre une femme, vivre seul, avoir un niveau d\u2019instruction et de revenu faible, de ne pas avoir occup\u00e9 un emploi au cours des 12 mois pr\u00e9c\u00e9dant l\u2019enqu\u00eate et pr\u00e9senter un trouble mental. Une exposition \u00e9lev\u00e9e aux diff\u00e9rents m\u00e9dicaments psychotropes (trois ou plus) a \u00e9t\u00e9 rapport\u00e9e chez 3,1\u00a0% des r\u00e9pondants. Toutes choses \u00e9tant \u00e9gales, elle augmente avec l\u2019\u00e2ge, le fait de vivre seul, ne pas avoir occup\u00e9 d\u2019emploi au cours de la derni\u00e8re ann\u00e9e et de pr\u00e9senter un trouble mental. Les r\u00e9sultats sugg\u00e8rent la n\u00e9cessit\u00e9 de consid\u00e9rer l\u2019isolement social et la pr\u00e9valence des troubles mentaux pour contextualiser l\u2019exposition \u00e9lev\u00e9e aux m\u00e9dicaments psychotropes puisque la polypharmacie peut pr\u00e9senter des risques importants si elle ne s\u2019inscrit pas dans la logique d\u2019un protocole d\u2019intervention clinique coh\u00e9rent.<\/jats:p>","DOI":"10.7202\/1019196ar","type":"journal-article","created":{"date-parts":[[2013,12,3]],"date-time":"2013-12-03T20:06:19Z","timestamp":1386101179000},"page":"259-278","source":"Crossref","is-referenced-by-count":1,"title":["Facteurs associ\u00e9s \u00e0 l\u2019exposition \u00e9lev\u00e9e aux m\u00e9dicaments psychotropes identifi\u00e9s lors d\u2019une \u00e9tude \u00e9pid\u00e9miologique montr\u00e9alaise"],"prefix":"10.7202","volume":"38","author":[{"suffix":"Ph.D","given":"Michel","family":"Perreault","sequence":"first","affiliation":[{"name":"Institut universitaire en sant\u00e9 mentale Douglas, Montr\u00e9al, Qu\u00e9bec"},{"name":"D\u00e9partement de psychiatrie, Universit\u00e9 McGill, Montr\u00e9al, Qu\u00e9bec"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Ph.D.","given":"Djema\u00e2-Samia","family":"Mechakra-Tahiri","sequence":"additional","affiliation":[{"name":"Institut universitaire en sant\u00e9 mentale Douglas, Montr\u00e9al, Qu\u00e9bec"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Ph.D.","given":"Marie-Jos\u00e9e","family":"Fleury","sequence":"additional","affiliation":[{"name":"Institut universitaire en sant\u00e9 mentale Douglas, Montr\u00e9al, Qu\u00e9bec"},{"name":"D\u00e9partement de psychiatrie, Universit\u00e9 McGill, Montr\u00e9al, Qu\u00e9bec"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Ph.D.","given":"El Hadj","family":"Tour\u00e9","sequence":"additional","affiliation":[{"name":"Institut universitaire en sant\u00e9 mentale Douglas, Montr\u00e9al, Qu\u00e9bec"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Institut universitaire en sant\u00e9 mentale Douglas, Montr\u00e9al, Qu\u00e9bec"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Ph.D.","given":"Jean","family":"Caron","sequence":"additional","affiliation":[{"name":"Institut universitaire en sant\u00e9 mentale Douglas, Montr\u00e9al, Qu\u00e9bec"},{"name":"D\u00e9partement de psychiatrie, Universit\u00e9 McGill, Montr\u00e9al, Qu\u00e9bec"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4194","published-online":{"date-parts":[[2013,10,30]]},"reference":[{"key":"rb1","doi-asserted-by":"crossref","unstructured":"Alessi-Severini, S., Biscontri, R. G., Collins, D. M., Kozyrskyj, A., Sareen, J., & Enns, M. W. (2008). Utilization and costs of antipsychotic agents\u00a0: a Canadian population-based study, 1996-2006, Psychiatr Serv, 59(5), 547-553.","DOI":"10.1176\/ps.2008.59.5.547"},{"key":"rb2","doi-asserted-by":"crossref","unstructured":"Alla, F., & Baumann, M. (2003). 5 year trajectories for dependence to psychotropics in a cohort of consumers, Therapie, 58(2), 145-151.","DOI":"10.2515\/therapie:2003021"},{"key":"rb3","doi-asserted-by":"crossref","unstructured":"Allard, J., Allaire, D., Leclerc, G., & Langlois, S.-P. (1997). L\u2019influence des relations familiales et sociales sur la consommation de m\u00e9dicaments psychotropes chez les personnes \u00e2g\u00e9es, Sant\u00e9 mentale au Qu\u00e9bec, 22(1), 164-182.","DOI":"10.7202\/502101ar"},{"key":"rb4","doi-asserted-by":"crossref","unstructured":"Beck, C. A., Williams, J. V., Wang, J. L., Kassam, A., El-Guebaly, N., Currie, S. R., Patten, S. B., 2005, Psychotropic medication use in Canada, Can J Psychiatry, 50(10), 605-613.","DOI":"10.1177\/070674370505001006"},{"key":"rb5","doi-asserted-by":"crossref","unstructured":"Blanc, M. E., & Marchand, A. (2010). The contribution of work and other social determinants to the onset of psychotropic drug use among workers in Canada, Can J Public Health, 101 Suppl 1, S63-68.","DOI":"10.1007\/BF03403849"},{"key":"rb6","doi-asserted-by":"crossref","unstructured":"Caron, J., Fleury, M. J., Perreault, M., Crocker, A., Tremblay, J., Tousignant, M., Daniel, M. (2012). Prevalence of psychological distress and mental disorders, and use of mental health services in the epidemiological catchment area of Montreal South-West, BMC Psychiatry, 12(1), 183.","DOI":"10.1186\/1471-244X-12-183"},{"key":"rb7","doi-asserted-by":"crossref","unstructured":"Caron, J., & Liu, A. (2010). A descriptive Study on the Prevalence of Psychological Distress and Mental Disorders in the Canadian Population\u00a0: Comparaison between Low-income and Non Low-income Populations, Chronic Diseases in Canada, 30(3), 84-94.","DOI":"10.24095\/hpcdp.30.3.03"},{"key":"rb8","doi-asserted-by":"crossref","unstructured":"Chien, I. C., Hsu, J. H., Bih, S. H., Lin, C. H., Chou, Y. J., Lee, C. H., & Chou, P. (2008). Prevalence, correlates, and disease patterns of antipsychotic use in Taiwan, Psychiatry Clin Neurosci, 62(6), 677-684.","DOI":"10.1111\/j.1440-1819.2008.01869.x"},{"key":"rb9","doi-asserted-by":"crossref","unstructured":"Cohidon, C., Alla, F., Chau, N., & Michaely, J. P. (2005). Tobacco, alcohol and psychotropic drugs in Lorraine, epidemiological survey of the general population, Sante Publique, 17(3), 325-338.","DOI":"10.3917\/spub.053.0325"},{"key":"rb10","unstructured":"Comit\u00e9 permanent de lutte \u00e0 la toxicomanie (2003). La consommation de psychotropes\u00a0: portrait et tendances au Qu\u00e9bec. Retrieved from http:\/\/www.stat.gouv.qc.ca\/publications\/sante\/troubles_mentaux.htm (consult\u00e9 le 10 ao\u00fbt 2012)"},{"key":"rb11","doi-asserted-by":"crossref","unstructured":"Empereur, F., Baumann, M., Alla, F., & Briancon, S. (2003). Factors associated with the consumption of psychotropic drugs in a cohort of men and women aged 50 and over, J Clin Pharm Ther, 28(1), 61-68.","DOI":"10.1046\/j.1365-2710.2003.00464.x"},{"key":"rb12","unstructured":"Enqu\u00eate nationale sur la sant\u00e9 de la population (ENSP) (2003-2005), from http:\/\/www.hc-sc.gc.ca\/fn-an\/surveill\/nutrition\/population\/index-fra.php (consult\u00e9 le 15 septembre 2011)"},{"key":"rb13","unstructured":"Enqu\u00eate sur la sant\u00e9 dans les collectivit\u00e9s canadiennes (cycle 1.2), (2009). Utilisation de services et consommation de m\u00e9dicaments li\u00e9es aux probl\u00e8mes de sant\u00e9 mentale chez les adultes qu\u00e9b\u00e9cois, from http:\/\/www.stat.gouv.qc.ca\/publications\/sante\/pdf2009\/medicaments_sante_mentale.pdf (consult\u00e9 le 30\u00a0septembre 2011)"},{"key":"rb14","doi-asserted-by":"crossref","unstructured":"Essock, S., Covell, N., Leckman-Westin, E., Lieberman, J., Sederer, L., Kealey, E., & Finnerty, M. (2009). Identifying clinically questionable psychotropic prescribing practices for Medicaid recipients in New York State, Psychiatric Services, 60(12), 1595-1602.","DOI":"10.1176\/ps.2009.60.12.1595"},{"key":"rb15","doi-asserted-by":"crossref","unstructured":"Glass, J., Lanct\u00f4t, K. L., Herrmann, N., Sproule, B. A., & Busto, U. E. (2005). Sedative hypnotics in older people with insomnia\u00a0: meta-analysis of risks and benefits, Bmj, 331(7526), 1169.","DOI":"10.1136\/bmj.38623.768588.47"},{"key":"rb16","doi-asserted-by":"crossref","unstructured":"Glezer, A., Byatt, N., Cook Jr, R., & Rothschild, A. J. (2009). Polypharmacy prevalence rates in the treatment of unipolar depression in an outpatient clinic, Journal of affective disorders, 117(1), 18-23.","DOI":"10.1016\/j.jad.2008.11.016"},{"key":"rb17","doi-asserted-by":"crossref","unstructured":"Hall, W. D., Mant, A., Mitchell, P. B., Rendle, V. A., Hickie, I. B., & McManus, P. (2003). Association between antidepressant prescribing and suicide in Australia, 1991-2000\u00a0: trend analysis, BMJ, 326(7397), 1008.","DOI":"10.1136\/bmj.326.7397.1008"},{"key":"rb18","doi-asserted-by":"crossref","unstructured":"Hemels, M. E., Koren, G., & Einarson, T. R. (2002). Increased use of antidepressants in Canada\u00a0: 1981-2000, Ann Pharmacother, 36(9), 1375-1379.","DOI":"10.1345\/aph.1A331"},{"key":"rb19","doi-asserted-by":"crossref","unstructured":"Hohmann, A. A. (1989). Gender bias in psychotropic drug prescribing in primary care, Med Care, 27(5), 478-490.","DOI":"10.1097\/00005650-198905000-00004"},{"key":"rb20","unstructured":"Hollingworth, S. A., Burgess, P. M., & Whiteford, H. A. (2003). Affective and anxiety disorders\u00a0: prevalence, treatment and antidepressant medication use, Aust N Z J Psychiatry, 44(6), 513-519."},{"key":"rb21","doi-asserted-by":"crossref","unstructured":"Johnell, K., Fastbom, J., Rosen, M., & Leimanis, A. (2007). Innapropriate drug use in the elderly\u00a0: a nationwide register-based study, Ann Pharmacother, 41(7), 1243-1248.","DOI":"10.1345\/aph.1K154"},{"key":"rb22","unstructured":"Kairouz, S., Boyer, R., Nadeau, L., Perreault, M., & Fiset-Laniel, J. (2008) Troubles mentaux, toxicomanie et autres probl\u00e8mes li\u00e9s \u00e0 la sant\u00e9 mentale chez les adultes qu\u00e9b\u00e9cois. Enqu\u00eate sur la sant\u00e9 dans les collectivit\u00e9s canadiennes (cycle 1.2), from www.stat.gouv.qc.ca\/publications\/sante\/troubles_mentaux.htm (consult\u00e9 le 10 juillet 2012)"},{"key":"rb23","doi-asserted-by":"crossref","unstructured":"Kaye, J. A., Bradbury, B. D., & Jick, H. (2003). Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000\u00a0: a population-based observational study, Br J Clin Pharmacol, 56(5), 569-575.","DOI":"10.1046\/j.1365-2125.2003.01905.x"},{"key":"rb24","doi-asserted-by":"crossref","unstructured":"Kessler, R. C., Wittchen, H. U., Abelson, J. M., McGonagle, K., Schwarz, N., Kendler, K. S., Zhao, S. (1998). Methodological studies of the Composite International Diagnostic Interview (CIDI) in the US National Comorbidity Survey (NCS), International Journal of Methods in Psychiatric Research, 7(4), 210-211.","DOI":"10.1002\/mpr.33"},{"key":"rb25","doi-asserted-by":"crossref","unstructured":"Kivimaki, M., Honkonen, T., Wahlbeck, K., Elovainio, M., Pentti, J., Klaukka, T., Vahtera, J., 2007, Organisational downsizing and increased use of psychotropic drugs among employees who remain in employment, J Epidemiol Community Health, 61(2), 154-158.","DOI":"10.1136\/jech.2006.050955"},{"key":"rb26","doi-asserted-by":"crossref","unstructured":"Klarin, I., Wimo, A., & Fastbom, J. (2005). The association of inappropriate drug use with hospitalization and mortality\u00a0: a population-based study of the very old, Drugs Aging, 22(1), 69-82.","DOI":"10.2165\/00002512-200522010-00005"},{"key":"rb27","doi-asserted-by":"crossref","unstructured":"Lau, D. T., Kasper, J. D., Potter, D. E., Lyles, A., & Bennett, R. G. (2005). Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents, Arch Intern Med, 165(1), 68-74.","DOI":"10.1001\/archinte.165.1.68"},{"key":"rb28","unstructured":"Laurier, C., Dumas, J., Gr\u00e9goire, J.-P., & Duvak, L. (1990). L\u2019utilisation des tranquillisants, s\u00e9datifs et somnif\u00e8res\u00a0: analyse des donn\u00e9es de l\u2019enqu\u00eate Sant\u00e9 Qu\u00e9bec 1987. Direction des communications, minist\u00e8re de la Sant\u00e9 et des Services sociaux\u00a0: Gouvernement du Qu\u00e9bec."},{"key":"rb29","doi-asserted-by":"crossref","unstructured":"Lesen, E., Andersson, K., Petzold, M., & Carlsten, A. (2010). Socioeconomic determinants of psychotropic drug utilisation among elderly\u00a0: a national population-based cross-sectional study, BMC Public Health, 10, 118.","DOI":"10.1186\/1471-2458-10-118"},{"key":"rb30","doi-asserted-by":"crossref","unstructured":"McDonough, P., 2000, Job insecurity and health, Int J Health Serv, 30(3), 453-476.","DOI":"10.2190\/BPFG-X3ME-LHTA-6RPV"},{"key":"rb31","doi-asserted-by":"crossref","unstructured":"Mojtabai, R., & Olfson, M. (2010). National trends in psychotropic medication polypharmacy in office-based psychiatry, Archives of General Psychiatry, 67(1), 26-36.","DOI":"10.1001\/archgenpsychiatry.2009.175"},{"key":"rb32","doi-asserted-by":"crossref","unstructured":"Morton, L. M., Cahill, J., & Hartge, P. (2006). Reporting participation in epidemiologic studies\u00a0: a survey of practice, Am J Epidemiol, 163, 197-203.","DOI":"10.1093\/aje\/kwj036"},{"key":"rb33","doi-asserted-by":"crossref","unstructured":"Patrick, V., Levin, E., & Schlieffer, S. (2005). Antipsychotic polypharmacy\u00a0: is there evidence for its use\u00a0?, Journal of Psychiatric Practice, 11(4), 248-257.","DOI":"10.1097\/00131746-200507000-00005"},{"key":"rb34","doi-asserted-by":"crossref","unstructured":"Percudani, M., Barbui, C., Fortino, I., & Petrovich, L. (2005). Epidemiology of first- and second-generation antipsychotic agents in Lombardy, Italy, Pharmacopsychiatry, 38(3), 128-131.","DOI":"10.1055\/s-2005-864124"},{"key":"rb35","doi-asserted-by":"crossref","unstructured":"Perri, M., Menon, A. M., Deshpande, A. D., Shinde, S. B., Jiang, R., Cooper, J. W., Cook, C. L., Griffin, S. C., Lorys, R. A. (2005). Adverse outcomes associated with inappropriate drug use in nursing homes, Ann Pharmacother, 39(3), 405-411.","DOI":"10.1345\/aph.1E230"},{"key":"rb36","doi-asserted-by":"crossref","unstructured":"Preskorn, S. H., & Lacey, R. L. (2007). Polypharmacy\u00a0: when is it rational\u00a0?, Journal of Psychiatric Practice, 13(2), 97-105.","DOI":"10.1097\/01.pra.0000265766.25495.3b"},{"key":"rb37","doi-asserted-by":"crossref","unstructured":"Reseland, S., Bray, I., & Gunnell, D. (2006). Relationship between antidepressant sales and secular trends in suicide rates in the Nordic countries, Br J Psychiatry, 188, 354-358.","DOI":"10.1192\/bjp.188.4.354"},{"key":"rb38","doi-asserted-by":"crossref","unstructured":"Trinkoff, A. M., & Anthony, J. C. (1990). Gender differences in initiation of psychotherapeutic medicine use, Acta Psychiatr Scand, 81(1), 32-38.","DOI":"10.1111\/j.1600-0447.1990.tb06445.x"},{"key":"rb39","unstructured":"Turpide, B., & Joseph, G. (2006). Portrait sociod\u00e9mographique, socio\u00e9conomique et scolaire de la r\u00e9gion de Montr\u00e9al, from http:\/\/www.centre123go.ca\/upload\/documents\/62A2B479-2DA8-0507-B71E-33334FA113D1-portrait_montreal_QEF.pdf (consult\u00e9 le 12 septembre 2011)"},{"key":"rb40","doi-asserted-by":"crossref","unstructured":"Zhornitsky, S., Potvin, S., Moteshafi, H., Dubreucq, S., Rompr\u00e9, P. P., & Stip, E. (2011) Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders\u00a0: a systematic review of the placebo-controlled monotherapy and add-on trials, Int Clin Psychopharmacol, 26(4), 183-92.","DOI":"10.1097\/YIC.0b013e3283430a0e"}],"container-title":["Sant\u00e9 mentale au Qu\u00e9bec"],"original-title":[],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T15:56:51Z","timestamp":1682438211000},"score":1,"resource":{"primary":{"URL":"http:\/\/id.erudit.org\/iderudit\/1019196ar"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,30]]},"references-count":40,"issue-title":["Dossier\u00a0: Mosa\u00efques"],"journal-issue":{"issue":"1"},"alternative-id":["1019196ar"],"URL":"https:\/\/doi.org\/10.7202\/1019196ar","relation":{},"ISSN":["1708-3923","0383-6320"],"issn-type":[{"type":"electronic","value":"1708-3923"},{"type":"print","value":"0383-6320"}],"subject":[],"published":{"date-parts":[[2013,10,30]]}}}